An Observational, Multicenter Study Evaluating the Safety of ReAl-lifePertuzumab and Trastuzumab Fixed Dose Combination: the RAPID Study
Clinical trial NCT06835348 · COMPLETED
Trial details
- NCT number
- NCT06835348
- Sponsor
- Fondazione Oncotech
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-03
- Primary completion
- 2024-11-29
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.